Patents by Inventor Bernd Neises

Bernd Neises has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7582794
    Abstract: The invention relates to a process for the preparation of a compound of the general formula (I) in which a) a compound (II) is reacted in the presence of a base B1 with a compound (III) and b) the compound (IV) formed as intermediate in step a) is reacted in the presence of a base B2 with a compound (V) to give the compound of the general formula (I)
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: September 1, 2009
    Assignee: sanofi-aventis Deutschland GmbH
    Inventors: Wolfgang Fiedler, Bernd Neises, Jochen Hachtel
  • Publication number: 20070219395
    Abstract: The invention relates to a process for the preparation of a compound of the general formula (I) in which a) a compound (II) is reacted in the presence of a base B1 with a compound (III) and b) the compound (IV) formed as intermediate in step a) is reacted in the presence of a base B2 with a compound (V) to give the compound of the general formula (I)
    Type: Application
    Filed: May 30, 2007
    Publication date: September 20, 2007
    Applicant: Sanofi-Aventis Deutschland GmbH
    Inventors: Wolfgang Fiedler, Bernd Neises, Jochen Hachtel
  • Patent number: 7238835
    Abstract: The invention relates to a process for the preparation of a compound of the general formula (I) in which a) a compound (II) is reacted in the presence of a base B1 with a compound (III) and b) the compound (IV) formed as intermediate in step a) is reacted in the presence of a base B2 with a compound (V) to give the compound of the general formula (I)
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: July 3, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Wolfgang Fiedler, Bernd Neises, Jochen Hachtel
  • Publication number: 20050171205
    Abstract: The invention relates to a process for the preparation of a compound of the general formula (I) in which a) a compound (II) is reacted in the presence of a base B1 with a compound (III) and b) the compound (IV) formed as intermediate in step a) is reacted in the presence of a base B2 with a compound (V) to give the compound of the general formula (I)
    Type: Application
    Filed: December 21, 2004
    Publication date: August 4, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Wolfgang Fiedler, Bernd Neises, Jochen Hachtel
  • Publication number: 20050143456
    Abstract: The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.
    Type: Application
    Filed: November 1, 2004
    Publication date: June 30, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Elisabeth Defossa, Thomas Klabunde, Hans-Joerg Burger, Andreas Herling, Erich Roedern, Stefan Peukert, Alfons Enhsen, Armin Bauer, Bernd Neises, Karl Wendt
  • Patent number: 6894184
    Abstract: A process is described for producing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamide, in which a phenyl-substituted 2-cyano-N-(phenyl)acetamide is reacted in the presence of a base, acetic anhydride and at least one solvent, and the resultant 2-cyano-3-hydroxy-N-(phenyl-derivative)but-2-enamide is crystallized by acidification.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: May 17, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Jochen Hachtel, Bernd Neises, Wilfried Schwab, Roland Utz, Martin Zahn
  • Patent number: 6812250
    Abstract: The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives. Compounds of the formula I in which the radicals have the stated meanings, and the physiologically tolerated salts thereof and process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: November 2, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Elisabeth Defossa, Thomas Klabunde, Hans-Joerg Burger, Andreas Herling, Erich von Roedern, Stefan Peukert, Alfons Enhsen, Armin Bauer, Bernd Neises, Karl Ulrich Wendt
  • Publication number: 20040186173
    Abstract: A process is described for producing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamide, in which a phenyl-substituted 2-cyano-N-(phenyl)acetamide is reacted in the presence of a base, acetic anhydride and at least one solvent, and the resultant 2-cyano-3-hydroxy-N-(phenyl-derivative)but-2-enamide is crystallized by acidification.
    Type: Application
    Filed: March 17, 2004
    Publication date: September 23, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Jochen Hachtel, Bernd Neises, Wilfried Schwab, Roland Utz, Martin Zahn
  • Publication number: 20030176497
    Abstract: The invention relates to carboxamide-substituted phenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives.
    Type: Application
    Filed: May 24, 2002
    Publication date: September 18, 2003
    Inventors: Elisabeth Defossa, Thomas Klabunde, Hans-Joerg Burger, Andreas Herling, Erich von Roedern, Stefan Peukert, Alfons Enhsen, Armin Bauer, Bernd Neises, Karl Ulrich Wendt